Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
about
Antibiotics for secondary prevention of coronary heart diseaseFifty years of stroke researches in IndiaChlamydia pneumoniae and atherosclerosis.Is cardiovascular disease preventable by vaccination?Chlamydia pneumoniae and coronary heart disease.Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosisHelicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease.Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studiesInfections and atherosclerosis.Immunological basis of Chlamydia induced reactive arthritis.Microorganisms in the aetiology of atherosclerosis.Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)The role of risk factors in the development of atherosclerosis.The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease.Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus.Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infectionEffects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis.Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: A case-control studyChlamydia pneumoniae (TWAR).Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesisExperimental rabbit models of Chlamydia pneumoniae infectionThematic review series: patient-oriented research. Imaging atherosclerosis: state of the art.Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms.Chlamydiae as pathogens: new species and new issues.Chlamydia pneumoniae in atheroma: consideration of criteria for causality.Why should a doctor be interested in oral disease?Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical optionsChlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infectionIncreased prevalence of Chlamydophila pneumoniae but not Epstein-Barr antibodies in essential hypertensives.Early impairment of coronary flow reserve is not associated with Chlamydia pneumoniae antibodies.Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.The significance of Chlamydia pneumoniae in symptomatic carotid stenosis.T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens.Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cellsCan an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.Chlamydia pneumoniae infection and ethnic origin.Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm.Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s).Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes.
P2860
Q24201388-B54ACF48-3E14-4DF5-99AA-9F7573886FB5Q26751807-60D9E837-8E7D-410E-B0C4-6C804F4FF848Q33534714-01C2F258-D2FB-4DAE-A3A6-8579B49D7028Q33603398-8511C109-8F73-44C7-9010-1F20B9DA5543Q33659387-85A78650-7109-4543-94F7-DA8BC06DAFA2Q33821294-9A9D156E-68E6-424A-B9F1-0BB8548E4290Q33821315-794B6428-0290-4665-A94B-52C1BC86FF30Q33905858-1666EFD1-492B-4FC4-AED3-0BFDC254EB3AQ33921219-3C498285-8056-4BFC-A04A-9CE5E3F45EECQ34015063-0AAFFE73-C0E6-4BCE-A51F-75240C4DA176Q34065709-F1456451-129C-4817-A888-136DF2A5D707Q34086738-E0EB2A7C-498D-40F5-AB8B-BD74744ABBC0Q34447107-A24FDCA7-0705-4612-B44A-8E4A24F6095EQ34557697-A31D116E-EDE6-421D-AE3A-A0966D5CAC4DQ34605079-F6042E70-D0D6-4ECE-9D5B-C07A98B8079AQ35091533-5E2E0E5D-510A-493C-B970-75E7CDDA5984Q35110637-49A7BA9C-BED4-4CE1-9EB7-A44F8D333F47Q35121619-2CE362CF-B2D8-4BEA-9521-703E150F2506Q35367697-7628AAB3-3222-4C90-AAF6-39B1D8E239CEQ35764383-21EF12C7-E454-46F4-91D8-7A8CEFC5FB6AQ35774105-E2370AD9-89B3-478D-BA83-787F71E240BBQ36480698-C8A68A22-1B68-4E01-B263-92E1E03EF3CBQ36541516-1C5D45D0-FB7B-4343-B218-E100EC29666EQ36838445-18FEFD07-516A-457F-A84B-6DE5E898C2DEQ37228857-38CC73E2-50AF-4324-8A04-C12930FF481DQ37799367-12366714-3F30-473C-A020-351D14D9B9EEQ37856198-0D0B4612-FEDB-4456-8DF1-5720BF38C1A6Q37861022-EB733B75-4BF7-41DA-9349-889D2CD457C0Q37870220-76E85DE3-C613-4170-AB0D-622E77DAB4C0Q37871079-9C6E0ACF-567A-4A6D-80A8-A79DC90C944FQ37873100-C23BDA7C-C519-4E0D-A5DE-5382C07F4C0CQ37873368-864D3FDE-D096-478F-81C8-4CF02CC2D94EQ37875919-AF5AE4A7-325B-4DBE-A681-4AFFE73F12B3Q37876249-42E4EB71-C6DB-4F5E-AC3C-0ABEABBA22F9Q37877470-B4D9854B-FF52-4B04-9F3F-210A7316AF42Q37877605-14E751BA-6501-4C02-AC7B-F681D03BC557Q37878142-1E30B4CA-7F55-4C92-B731-81DD2D461738Q37878292-9B995AD1-9958-4EDA-9203-5BA4A2FD1E52Q37878378-6245B8BB-4206-4986-82C4-3706D32B6E2CQ37879018-453D4161-3405-4DD5-B7FE-F3FFBE7B976A
P2860
Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Past infection by Chlamydia pn ...... es (ARIC) Study Investigators.
@en
Past infection by Chlamydia pn ...... osclerosis Risk in Communities
@nl
type
label
Past infection by Chlamydia pn ...... es (ARIC) Study Investigators.
@en
Past infection by Chlamydia pn ...... osclerosis Risk in Communities
@nl
prefLabel
Past infection by Chlamydia pn ...... es (ARIC) Study Investigators.
@en
Past infection by Chlamydia pn ...... osclerosis Risk in Communities
@nl
P2093
P1476
Past infection by Chlamydia pn ...... es (ARIC) Study Investigators.
@en
P2093
Grayston JT
Melnick SL
P304
P356
10.1016/0002-9343(93)90332-J
P407
P577
1993-11-01T00:00:00Z